​

NuCana (NCNA) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

NCNA Stock Rating

NuCana stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

NCNA Price Target Upside V Benchmarks

TypeNameUpside
StockNuCana-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.20$4.20$4.20
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25--1--1
May, 25--1--1
Apr, 25--1--1
Mar, 25-12--3
Feb, 25-11--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 29, 2024William BlairMarket Performdowngrade
Aug 19, 2024OppenheimerOutperformOutperformhold
Jul 22, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.53-----
Avg Forecast$-0.12$-0.40$-0.29$-0.29$-0.88$-0.49
High Forecast$-0.11$-0.37$-0.25$-0.02$-0.13$-0.49
Low Forecast$-0.15$-0.44$-0.33$-0.56$-1.63$-0.49
Surprise %341.67%-----

Revenue Forecast

$0 $6M $12M $18M $24M $30M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$1.25M$3.74M$9.66M$26.24M
High Forecast--$1.25M$3.74M$9.66M$26.24M
Low Forecast--$1.25M$3.74M$9.66M$26.24M
Surprise %------

Net Income Forecast

$-30M $-24M $-18M $-12M $-6M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.63M-----
Avg Forecast$-270.46K$-846.32K$-608.97K$-611.75K$-1.86M$-1.03M
High Forecast$-231.83K$-769.97K$-522.21K$-36.60K$-274.03K$-1.03M
Low Forecast$-309.09K$-922.67K$-695.73K$-1.19M$-3.44M$-1.03M
Surprise %10116.67%-----

NCNA Forecast FAQ

Is NuCana stock a buy?

NuCana stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that NuCana is a favorable investment for most analysts.

What is NuCana's price target?

NuCana's price target, set by 8 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.2.

How does NuCana stock forecast compare to its benchmarks?

NuCana's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for NuCana over the past three months?

  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is NuCana’s EPS forecast?

NuCana's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.4, marking a -24.53% decrease from the reported $-0.53 in 2023. Estimates for the following years are $-0.29 in 2025, $-0.29 in 2026, $-0.88 in 2027, and $-0.49 in 2028.

What is NuCana’s revenue forecast?

NuCana's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $1.25M, followed by $3.74M for 2026, $9.66M for 2027, and $26.24M for 2028.

What is NuCana’s net income forecast?

NuCana's net income forecast for the fiscal year ending in December 2024 stands at $-846K, representing a -96.94% decrease from the reported $-27.632M in 2023. Projections indicate $-609K in 2025, $-612K in 2026, $-1.859M in 2027, and $-1.033M in 2028.